Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (10): 99-109.doi: 10.6040/j.issn.1671-7554.0.2022.0265
Previous Articles Next Articles
XIU Dejian1,2, GAO Zhengwen3, SONG Tingting4, CUI Nan5, CUI Jing6, SUN Jianping6
CLC Number:
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. [2] Gaffney DK, Hashibe M, Kepka D, et al. Too many women are dying from cervix cancer: problems and solutions[J]. Gynecol Oncol, 2018, 151(3): 547-554. [3] Castle PE, Einstein MH, Sahasrabuddhe VV. Cervical cancer prevention and control in women living with human immunodeficiency virus[J]. CA Cancer J Clin, 2021, 71(6): 505-526. [4] Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer[J]. Lancet, 2019, 393(10167): 169-182. [5] Olusola P, Banerjee HN, Philley JV, et al. Human papilloma virus-associated cervical cancer and health disparities[J]. Cells, 2019, 8(6): 622. [6] Asthana S, Busa V, Labani S. Oral contraceptives use and risk of cervical cancer-a systematic review & meta-analysis[J]. Eur J Obstet Gynecol Reprod Biol, 2020, 247: 163-175. doi: 10.1016/j.ejogrb.2020.02.014. [7] 赵庆庆, 尹格平. TNF-α启动子5个位点的基因多态性与山东省汉族妇女宫颈癌遗传易感性的相关性[J]. 山东大学学报(医学版), 2018, 56(2): 28-33. ZHAO Qingqing, YIN Geping. Association between genetic polymorphisms of 5 genetic loci of TNF-α promoter and genetic susceptibility to cervical cancer[J]. Journal of Shandong University(Health Sciences), 2018, 56(2): 28-33. [8] Liontos M, Kyriazoglou A, Dimitriadis I, et al. Systemic therapy in cervical cancer: 30 years in review[J]. Crit Rev Oncol Hematol, 2019, 137: 9-17. doi: 10.1016/j.critrevonc.2019.02.009. [9] Feng CH, Mell LK, Sharabi AB, et al. Immunotherapy with radiotherapy and chemoradiotherapy for cervical cancer[J]. Semin Radiat Oncol, 2020, 30(4): 273-280 [10] 杨佳欣, 沈铿, 王遥. 妇科恶性肿瘤保留生育功能治疗的现状与展望[J]. 山东大学学报(医学版), 2018, 56(5): 1-7. YANG Jiaxin, SHEN Keng, WANG Yao. Status and prospect of fertility preservation treatment for gynecologic malignancies[J]. Journal of Shandong University(Health Sciences), 2018, 56(5): 1-7. [11] Mauricio D, Zeybek B, Tymon-Rosario J, et al. Immunotherapy in cervical cancer[J]. Curr Oncol Rep, 2021, 23(6): 61. [12] Wright JD, Matsuo K, Huang Y, et al. Prognostic performance of the 2018 international federation of gynecology and obstetrics cervical cancer staging guidelines[J]. Obstet Gynecol, 2019, 134(1): 49-57. [13] Aalijahan H, Ghorbian S. Long non-coding RNAs and cervical cancer[J]. Exp Mol Pathol, 2019, 106: 7-16. doi: 10.1016/j.yexmp.2018.11.010. [14] Wu X, Peng L, Zhang Y, et al. Identification of key genes and pathways in cervical cancer by bioinformatics analysis[J]. Int J Med Sci, 2019, 16(6): 800-812. [15] Yang HJ, Xue JM, Li J, et al. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis[J]. Mol Genet Genomic Med, 2020, 8(6): e1200. [16] Wu K, Yi Y, Liu F, et al. Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis[J]. Oncol Lett, 2018, 16(1): 1003-1009. [17] den Boon JA, Pyeon D, Wang SS, et al. Molecular transitions from papillomavirus infection to cervical precancer and cancer: role of stromal estrogen receptor signaling[J]. Proc Natl Acad Sci U S A, 2015, 112(25): E3255-E3264. [18] Tang X, Xu Y, Lu L, et al. Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy[J]. Cancer Manag Res, 2018, 10: 3533-3549. doi: 10.2147/CMAR.S171661. [19] Long NP, Jung KH, Yoon SJ, et al. Systematic assessment of cervical cancer initiation and progression uncovers genetic panels for deep learning-based early diagnosis and proposes novel diagnostic and prognostic biomarkers[J]. Oncotarget, 2017, 8(65): 109436-109456. [20] Peng X, Zhang Y, Gao J, et al. MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway[J]. Exp Mol Pathol, 2020, 114: 104368. doi:10.1016/j.yexmp.2020.104368. [21] Wei W, Liu C. Prognostic and predictive roles of microRNA411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer[J]. Mol Med Rep, 2020, 21(1): 267-281. [22] Yang WX, Pan YY, You CG. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 may be potential therapeutic targets for hepatocellular carcinoma using integrated bioinformatic analysis[J]. Biomed Res Int, 2019, 2019: 1245072. doi: 10.1155/2019/1245072. [23] Wang Y, Wang F, He J, et al. miR-30a-3p targets MAD2L1 and regulates proliferation of gastric cancer cells[J]. Onco Targets Ther, 2019, 12: 11313-11324. doi: 10.2147/OTT.S222854. [24] Ding X, Duan H, Luo H. Identification of core gene expression signature and key pathways in colorectal cancer[J]. Front Genet, 2020, 11: 45. doi: 10.3389/fgene.2020.00045. [25] Niu Y, Wang Z, Huang H, et al. Activated pregnane X receptor inhibits cervical cancer cell proliferation and tumorigenicity by inducing G2/M cell-cycle arrest[J]. Cancer Lett, 2014, 347(1): 88-97. [26] Wang L, Wang J, Jin Y, et al. Downregulation of Mad2 and BubR1 increase the malignant potential and nocodazole resistance by compromising spindle assembly checkpoint signaling pathway in cervical carcinogenesis[J]. J Obstet Gynaecol Res, 2019, 45(12): 2407-2418. [27] Dobles M, Liberal V, Scott ML, et al. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2[J]. Cell, 2000, 101(6): 635-645. [28] Jia D, Li S, Li D, et al. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment[J]. Aging(Albany NY), 2018, 10(4): 592-605. |
[1] | LI Linlin, WANG Kai. Prediction of hepatocellular carcinoma prognostic genes based on bioinformatics [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 50-58. |
[2] | CHEN Quancai, HAN Sai, LIU Lu, SUN Yu, YOU Xuewu, ZHANG Junhua, ZHANG Youzhong. Expressions and significance of CDC7 and MCM4 in 105 cases of cervical lesions [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 34-39. |
[3] | GENG Chen, YANG Yang, ZHAO Yue, LIU Haoran, CHAO Lan. Identification of differentially expressed genes and Wilms tumor-1 expression in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 79-86. |
[4] | HUA Fang, ZHANG Weiwei, LYU Bo, XIN Wei. Bioinformatic analysis of genes and molecular pathways associated with osteoarthritis synovitis [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 10-17. |
[5] | LIANG Tingting, YANG Yongxia, HOU Congzhe, HUANG Taisheng, WANG Huali, ZHU Lin. Correlation among PAX1 methylation, high-grade cervical intraepithelial lesions and HR-HPV classification [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 48-52. |
[6] | TANG Bo, SHAO Jing, CUI Jing, SUN Jianping. A mechanism study on the association of type 2 diabetes and high-density lipoprotein [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 99-106. |
[7] | ZHOU Huimei, YANG Jiaxin, CAO Dongyan, SHEN Keng, XIANG Yang, WU Ming, PAN Lingya, HUANG Huifang, LANG Jinghe. Fertility-sparing radical trachelectomy for young women with early stage cervical cancer: surgical and obstetrical outcomes [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 18-22. |
[8] | YANG Jiaxin, SHEN Keng, WANG Yao. Status and prospect of fertility preservation treatment for gynecologic malignancies [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 1-7. |
[9] | CHEN Ying, ZHOU Xiaoqing, QI Mei, ZHANG Weifang, LIU Juan, ZHAO Weiming. Effects of PRPS2 knockdown on the biological property of cervical cancer cells [J]. Journal of Shandong University (Health Sciences), 2018, 56(2): 9-13. |
[10] | WANG Hongyang. Development of tumor biomarkers in the age of precision medicine [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 1-2. |
[11] | WANG Yong, JIANG Chen, ZHOU Shiying, YANG Xiaomei. Effect of IQ motif-containing GTPase activating protein 3 on the proliferation and migration of cervical cancer cells [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 103-109. |
[12] | PAN Shiyang. Research advances in markers for the evaluation of lung cancer efficacy [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 31-39. |
[13] | GAO Chunfang, HUANG Chenjun. Cancer biomarkers of intrahepatic cholangiocarcinoma and the clinical application [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 24-30. |
[14] | LIU Jingkang, YANG Jianyong, MENG Lihua, JIANG Jie. The value of serum miR-17-92 cluster in early diagnosis of HPV-positive cervical cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 86-90. |
[15] | SUN Zeyu, CHEN Ying, LIN Jiaxiang, LIU Juan, ZHAO Weiming. Influence of inositol polyphosphate-4-phosphatase type II on the proliferation and apoptosis of cervical cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 1-6. |
|